EUVIMEDDescoperă EUVIMED
Crossref

Self‐Healable Hydrogel for Regression of Liver Fibrosis

Yu-Chai Tai, Wei-Rong Yin, Kai-Yi Cheng, Xin-Yu Chou, Yong-Heng Lin, Shan-Hui Hsu iD, Yung-Te Hou iD

Biotechnology and Bioengineering · 2025

DOI: 10.1002/bit.28966 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2025. Written by Yu-Chai Tai and 6 co-authors. Institution: Department of Biomechatronics Engineering, National Taiwan University, Taipei, Taiwan. Major MEDLINE topics: Liver Cirrhosis, Hydrogels, Chitosan. Cited 3 times so far (Crossref); 61 references. Funded by: This research was funded by the Research Proposal for NTU Core Consortiums of National Taiwan University (NTU-CC-110L892506, NTU-CC-111L891906, and NTU-CC-112L….

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Liver fibrosis is considered as a wound healing process in the presence of chronic hepatic injury. A hydrogel (CPDP) based on chitosan–phenol that undergoes fast gelling and owns self‐healing and injectable properties was investigated for the effect on regression of liver fibrosis. For the purpose, we established both in vitro and in vivo liver fibrosis models and implanted CPDP hydrogel into the injured liver. The CPDP hydrogel not only provided a suitable microenvironment for hepatocyte spheroids, but also demonstrated a potential for the hepatocyte spheroid‐embedded system to mimic the liver tissue in vitro. Furthermore, the urea synthesis of injured hepatocytes cultured on hepatocyte spheroid‐embedded CPDP hydrogel was 1.12 times higher than that on hepatocyte spheroid‐embedded collagen hydrogel after 7 days of culture, indicating that CPDP hydrogel effectively rescued hepatic function in the injured hepatocytes. Moreover, the hepatic injury was alleviated with improved hepatic function in the liver fibrosis model in vivo. A reduction of approximately 28% in serum AST/ALT ratios and a 70% decrease in the fibrotic area suggested the regression of liver fibrosis after 2 weeks of CPDP hydrogel administration. These findings suggest that CPDP hydrogel holds promise for applications in liver tissue engineering.

Subjects

MeSH terms (MEDLINE)

Liver CirrhosisHydrogelsChitosanAnimalsHepatocytesMaleMiceTissue EngineeringDisease Models, AnimalSpheroids, CellularRatsLiverHumans

Author keywords

hepatocyte spheroidsin vivo modelliver fibrosisself‐healing hydrogel

Substances

HydrogelsChitosan

Authors and institutions

  • Department of Biomechatronics Engineering, National Taiwan University, Taipei, Taiwan.
  • Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan.
  • Animal Resource Center, National Taiwan University, Taipei, Taiwan.

ORCID profiles: Shan-Hui Hsu, Yung-Te Hou

Funding

  • This research was funded by the Research Proposal for NTU Core Consortiums of National Taiwan University (NTU-CC-110L892506, NTU-CC-111L891906, and NTU-CC-112L…

Cite

APA

Tai, Y. C., Yin, W. R., Cheng, K. Y., Chou, X. Y., Lin, Y. H., Hsu, S. H., & Hou, Y. T. (2025). Self‐Healable Hydrogel for Regression of Liver Fibrosis. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28966

Vancouver

Tai YC, Yin WR, Cheng KY, Chou XY, Lin YH, Hsu SH, et al. Self‐Healable Hydrogel for Regression of Liver Fibrosis. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.28966

BibTeX
@article{Tai2025,
  author = {Tai, Yu-Chai and Yin, Wei-Rong and Cheng, Kai-Yi and Chou, Xin-Yu and Lin, Yong-Heng and Hsu, Shan-Hui and Hou, Yung-Te},
  title = {Self‐Healable Hydrogel for Regression of Liver Fibrosis},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  doi = {10.1002/bit.28966}
}
Start for free →